01 January 2001
Statin-stimulated nitric oxide release from endothelium.
Lawrence W Dobrucki, Leszek Kalinowski, Iwona T Dobrucki, Tadeusz MalinskiMed Sci Monit 2001; 7(4): BR622-627 :: ID: 421094
Abstract
BACKGROUND: There is increasing evidence that loss of endothelium-derivedNO is a major factor in cardiovascular complication events, and that NO might exert antiatheroscleroticactions. The beneficial effects of HMG CoA reductase inhibitors (statins) therapy in atherosclerosisoutweigh those expected from simply lowering low-density lipoprotein (LDL) cholesterol, and may be relatedto the direct action in the endothelium. Based on these concepts, in the studies described here, theeffect of new statin derivatives on nitric oxide (NO) and superoxide (O2-) release in bovine endothelialcells was tested.MATERIAL AND METHODS: Highly sensitive electrochemical NO and O2--microsensors wereplaced near the surface of endothelial cells, and the concurrent kinetics of NO and O2-- release weremeasured in situ.RESULTS: All tested statins stimulated NO release. The peak concentration of NO afterstimulation with 1 Kmol/l Lovastatin, 1 Kmol/l Atorvastatin, 1 Kmol/l Pravastatin, or 1 Kmol/l Simvastatinwas about 77%, 73%, 72%, and 44% lower, respectively, as compared with the NO peak concentration afterstimulation with 1 Kmol/l calcium ionophore A23187 (receptor-independent agonist). The tested statinsstimulated NO release in a modest way, which resulted in diminishing O2- generation during activationof nitric oxide synthase. Moreover, the kinetics of O2- release after administration of the statins suggestedthat these compounds may also scavenge O2-. The NO/O2- peak concentration ratio after the NOS agonistsadministration was as follows: 7.51 for CaI, 6.56 for Lovastatin, 6.00 for Atorvastatin, 4.17 for Pravastatinand 6.25 for Simvastatin.CONCLUSIONS: The tested statins, i.e. Lovastatin, Atorvastatin, Pravastatinand Simvastatin demonstrate variable potency to enhance the NO/O2- concentration ratio after stimulationof NOS, resulting in an increase of NO bioavailability in endothelial cells.
Keywords: statins, Endothelium, Nitric Oxide, superoxide
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
06 Mar 2024 : Clinical Research
Comparison of Outcomes between Single-Level and Double-Level Corpectomy in Thoracolumbar Reconstruction: A ...Med Sci Monit In Press; DOI: 10.12659/MSM.943797
21 Mar 2024 : Meta-Analysis
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...Med Sci Monit In Press; DOI: 10.12659/MSM.943863
10 Apr 2024 : Clinical Research
Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...Med Sci Monit In Press; DOI: 10.12659/MSM.942612
06 Mar 2024 : Clinical Research
Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...Med Sci Monit In Press; DOI: 10.12659/MSM.941102
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952